Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity - Supplement
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity - Supplement
批准号:
10600507
负责人:
Thomas Stoeger
金额:
$3.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2023-10-31
关键词:
AddressAgeAgingBioethicsBiology of AgingBuffersCOVID-19Cell physiologyCellular StressCellular biologyClinicalClinical DataCollaborationsDataData ScienceData ScientistData SetEnsureFailureFoundationsFunctional disorderGene ExpressionGene Expression ProfilingGenesGenomeGrantHealthHomeostasisImmuneImmunologistImpairmentIn VitroIndividualInflammatory ResponseInfluenzaInfluenza A virusLaboratoriesLearningLengthLinkLung infectionsMachine LearningMacromolecular ComplexesMentorsMolecularMorbidity - disease rateMusNatureOrganPathway interactionsPatientsPhasePostdoctoral FellowPredispositionProcessProteomePublishingRegulationResearchResearch PersonnelRunningScientistSiteStimulusStressSupervisionSystems AnalysisTechniquesTestingTimeTrainingTranscriptUp-RegulationViral PneumoniaWorkWritingage relatedagedbiological adaptation to stressin vivo Modelinsightmultiple chronic conditionsmultiple omicspost-doctoral trainingproteostasisresilienceresponseskillsstoichiometrytranscriptometranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The investigator identified through unbiased analysis of own and published datasets that during aging, and
infection of the lung with influenza A, there is a progressive imbalance in the transcript levels encoded by short
genes relative to those encoded by long genes (revision currently under review in Nature Aging). Failure of gene
expression homeostasis impacts the rheostatic ability of almost all cellular processes implicated in aging
impairing organ function, particularly in response to systemic stress. Transcriptome imbalance could account for
manifestations of aging through several potential mechanisms, including: 1) The dysregulation of individual
genes, 2) A dysregulation of the stoichiometry of macromolecular complexes, 3) A relative upregulation of short
early-response inflammatory genes, 4) A breakdown of the coordination between molecular pathways and
processes encoded by genes of different lengths and 5) A reduction in the capacity of protein homeostasis and
cell stress responses to respond towards external stimuli by sequestering its activity toward a buffering of
transcriptome imbalance. The investigator will test the hypothesis that during aging transcriptome imbalance
globally interferes with the functions encoded by the genome and contributes to the loss of resilience
in older individuals. To address this fundamental question, he suggested mammalian ex vivo, in vitro, and in
vivo models of age-dependent transcriptome imbalance, and machine-learning approaches, but because of
COVID-19 related availability refocused on latter and clinical and multi-omic patient data. Reflecting the
interdisciplinary character, he will work under the supervision of his main mentor Dr. Amaral, a network scientist
and data-scientist, and his co-mentor Dr. Morimoto, a molecular biologist studying protein homeostasis and
aging. Further marking his transition to independence, he will be mentored by Dr. Budinger, an immunologist
studying changes in immune aging, and Dr. McNally, a geneticist and bioinformatician, which is not part of a
project grant of his mentors. Aim 1 (K99): To gain mechanistic insight into the origin of transcriptome imbalance
in aging. Aim 2 (K99): To determine whether adaptive changes in proteostasis buffer transcriptome imbalance
during aging after viral pneumonia. Aim 3 (R00): To causally link transcriptome imbalance to the age-related
susceptibility to viral pneumonia. Importantly, the investigator’s mentoring committee has a very strong track
record of training postdoctoral fellows in transitioning into independent investigators. He will engage in seminars
and learn recent experimental techniques, grant writing, bioethics training, and training on running a laboratory,
and obtain additional off-site training on the biology of aging in mice with the purpose to facilitate collaborations.
Combining the new skills learned during his K99 mentored phase with his prior expertise in data science and
transcriptomics will ensure a strong technical foundation to launch an independent laboratory on gene expression
homeostasis in aging and the mechanisms underlying multi-system dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
-
批准号:10040210
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2020
-
负责人:Thomas Stoeger
-
依托单位:
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
-
批准号:10260623
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2020
-
负责人:Thomas Stoeger
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: